Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Therapeutic drug monitoring of immunosuppressant drugs.

Literature DB >> 10233195

Therapeutic drug monitoring of immunosuppressant drugs.

A Johnston¹, D W Holt.

Abstract

Mesh：

Substances：

Year: 1999 PMID： 10233195 PMCID： PMC2014241 DOI： 10.1046/j.1365-2125.1999.00911.x

Source DB: PubMed Journal: Br J Clin Pharmacol ISSN： 0306-5251 Impact factor: 4.335

× No keyword cloud information.

125 in total

Review 1. Consensus document: Hawk's Cay meeting on therapeutic drug monitoring of cyclosporine.

Authors: B D Kahan; L M Shaw; D Holt; J Grevel; A Johnston
Journal: Clin Chem Date: 1990-08 Impact factor: 8.327

2. Quality assessment issues of new immunosuppressive drugs and experimental experience.

Authors: D W Holt; K Jones; T Lee; P Stadler; A Johnston
Journal: Ther Drug Monit Date: 1996-08 Impact factor: 3.681

Review 3. Monitoring antithymocyte globulin in renal transplantation.

Authors: K Clark
Journal: Ann R Coll Surg Engl Date: 1996-11 Impact factor: 1.891

4. Mycophenolate mofetil for transplantation: new drug, old problems?

Authors: D W Gray
Journal: Lancet Date: 1995-08-12 Impact factor: 79.321

Review 5. Methodological and clinical aspects of cyclosporin monitoring: report of the Association of Clinical Biochemists task force.

Authors: D W Holt; A Johnston; N B Roberts; J M Tredger; A K Trull
Journal: Ann Clin Biochem Date: 1994-09 Impact factor: 2.057

6. SDZ RAD, a new rapamycin derivative: pharmacological properties in vitro and in vivo.

Authors: W Schuler; R Sedrani; S Cottens; B Häberlin; M Schulz; H J Schuurman; G Zenke; H G Zerwes; M H Schreier
Journal: Transplantation Date: 1997-07-15 Impact factor: 4.939

7. Pharmacokinetics and immunodynamics of chimeric IL-2 receptor monoclonal antibody SDZ CHI 621 in renal allograft recipients.

Authors: J M Kovarik; E Rawlings; P Sweny; O Fernando; R Moore; P J Griffin; P Fauchald; D Albrechtsen; G Sodal; K Nordal; P L Amlot
Journal: Transpl Int Date: 1996 Impact factor: 3.782

Review 8. Cyclosporin A: analytical methodology and factors affecting therapeutic drug monitoring.

Authors: D W Holt; A Johnston
Journal: Ther Drug Monit Date: 1995-12 Impact factor: 3.681

9. Cyclosporine plasma levels six hours after oral administration. A useful tool for monitoring therapy.

Authors: F Cantarovich; C Bizollon; D Cantarovich; N Lefrançois; J M Dubernard; J Traeger
Journal: Transplantation Date: 1988-02 Impact factor: 4.939

Review 10. Clinical pharmacokinetics of mycophenolate mofetil.

Authors: R E Bullingham; A J Nicholls; B R Kamm
Journal: Clin Pharmacokinet Date: 1998-06 Impact factor: 6.447

11 in total

1. Target concentration intervention: beyond Y2K.

Authors: N H Holford
Journal: Br J Clin Pharmacol Date: 1999-07 Impact factor: 4.335

Review 2. Immunosuppressive therapy for paediatric transplant patients: pharmacokinetic considerations.

Authors: María del Mar Fernández De Gatta; Dolores Santos-Buelga; Alfonso Domínguez-Gil; María José García
Journal: Clin Pharmacokinet Date: 2002 Impact factor: 6.447

3. Performance of the Dimension TAC assay and comparison of multiple platforms for the measurement of tacrolimus.

Authors: Eun-Jung Cho; Dae-Hyun Ko; Woochang Lee; Sail Chun; Hae-Kyung Lee; Won-Ki Min
Journal: J Clin Lab Anal Date: 2017-11-17 Impact factor: 2.352

Review 4. Alternative matrices for therapeutic drug monitoring of immunosuppressive agents using LC-MS/MS.

Authors: Mwlod Ghareeb; Fatemeh Akhlaghi
Journal: Bioanalysis Date: 2015 Impact factor: 2.681

Review 5. Methods for clinical monitoring of cyclosporin in transplant patients.

Authors: R J Dumont; M H Ensom
Journal: Clin Pharmacokinet Date: 2000-05 Impact factor: 6.447

Review 6. Mechanisms of clinically relevant drug interactions associated with tacrolimus.

Authors: Uwe Christians; Wolfgang Jacobsen; Leslie Z Benet; Alfonso Lampen
Journal: Clin Pharmacokinet Date: 2002 Impact factor: 6.447

Review 7. Mechanisms, Pathophysiology and Current Immunomodulatory/Immunosuppressive Therapy of Non-Infectious and/or Immune-Mediated Choroiditis.

Authors: Ioannis Papasavvas; Ilknur Tugal-Tutkun; Carl P Herbort
Journal: Pharmaceuticals (Basel) Date: 2022-03-24